Wockhardt Ltd.
| BSE: 532300 | Sector: Health care |
| NSE: WOCKPHARMA | ISIN Code: INE049B01025 |
| BSE 13:44 | 21 Mar | 172.85 |
4.05 (2.40%) |
OPEN
168.80 |
HIGH
173.70 |
LOW
167.10 |
| NSE 13:34 | 21 Mar | 172.70 |
3.85 (2.28%) |
OPEN
170.00 |
HIGH
173.20 |
LOW
167.00 |
| OPEN | 168.80 |
| PREVIOUS CLOSE | 168.80 |
| VOLUME | 42190 |
| 52-Week high | 334.35 |
| 52-Week low | 165.45 |
| P/E | |
| Mkt Cap.(Rs cr) | 2,490 |
| Buy Price | 172.85 |
| Buy Qty | 1163.00 |
| Sell Price | 173.20 |
| Sell Qty | 1.00 |
Wockhardt Ltd. (WOCKPHARMA) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 959.75 | -0.16 | 1071.90 | 789.75 | 230272.81 |
| Dr Reddy's Labs | 4441.25 | -0.01 | 4645.55 | 3787.55 | 73955.70 |
| Divi's Lab. | 2782.50 | -0.59 | 4640.95 | 2730.00 | 73861.46 |
| Cipla | 864.60 | -0.31 | 1185.20 | 853.50 | 69786.19 |
| Apollo Hospitals | 4294.00 | -0.27 | 4915.00 | 3365.90 | 61739.13 |
| Torrent Pharma. | 1515.95 | -0.40 | 1722.70 | 1242.50 | 51305.81 |
| Zydus Lifesci. | 475.55 | -0.06 | 488.10 | 319.40 | 48135.17 |
| Max Healthcare | 467.90 | -0.04 | 482.50 | 306.00 | 45429.35 |
| Abbott India | 21201.75 | -0.48 | 22481.80 | 15868.70 | 45053.72 |
| Alkem Lab | 3124.95 | 0.52 | 3720.00 | 2835.00 | 37358.78 |
| Lupin | 647.85 | 0.26 | 798.90 | 583.05 | 29477.18 |
| Aurobindo Pharma | 471.00 | -0.69 | 730.00 | 397.30 | 27595.89 |
| Biocon | 200.00 | -0.89 | 387.80 | 191.60 | 24012.00 |
| Syngene Intl. | 579.00 | 0.56 | 682.25 | 511.50 | 23242.80 |
| Glaxosmi. Pharma | 1292.40 | 0.83 | 1734.90 | 1230.70 | 21894.55 |
| Gland Pharma | 1207.00 | 3.71 | 3556.10 | 1130.40 | 19879.29 |
| Ipca Labs. | 783.45 | 0.33 | 1089.00 | 768.00 | 19876.13 |
| Fortis Health. | 252.45 | -3.07 | 324.80 | 219.80 | 19058.97 |
| Laurus Labs | 305.45 | 1.01 | 626.00 | 298.00 | 16453.06 |
| Pfizer | 3515.50 | -0.50 | 4662.35 | 3465.20 | 16083.41 |
Quick Links for Wockhardt:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
